Picture of Biocure Technology logo

CURE Biocure Technology Income Statement

0.000.00%
ca flag iconLast trade - 00:00
EnergySpeculativeMicro Cap

Annual income statement for Biocure Technology, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.

2007
September 30th
2008
September 30th
2009
September 30th
Period Length:1 M12 M12 M
Source:PROSPECTUSARSARS
Standards:
CAS
CAS
CAS
Status:FinalFinalFinal
Total Revenue000
Selling / General / Administrative Expenses
Total Operating Expenses0.0060.070.089
Operating Profit-0.006-0.07-0.089
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-0.006-0.066-0.087
Provision for Income Taxes
Net Income After Taxes-0.006-0.066-0.087
Net Income Before Extraordinary Items
Net Income-0.006-0.066-0.087
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income-0.006-0.066-0.087
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.002-0.073-0.043
Dividends per Share

Or unlock with your email

Or unlock with your email